Press Release Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets Aug 21
Press Release Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update Aug 19